Why Catalent?

Catalent’s broad and industry-leading cell therapy expertise enables access to comprehensive solutions to get your life-saving cell therapies to the clinic faster and commercialize them more efficiently. With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service partner for CAR-T immunotherapies and beyond.

Our unique and comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including chimeric antigen receptor T cells (CAR-T), T cell receptor (TCR), tumor-infiltrating leukocytes (TILs), natural killer cells (NKs), iPSCs, and MSCs.

MaSTherCell was recently acquired by Catalent. Click to read more about the deal.